Filters
Pimavanserin therapy was well tolerated in frail adult and older patients with neuropsychiatric symptoms related to neurodegenerative disease (NDD) in a recent study presented at AAIC 2023.
Switching from an integrase inhibitor (INI)-based antiretroviral treatment (ART) regimen to a protease inhibitor (PI)-based regimen falls short of reversing weight gain while on the INI-based regimen, according to the results of the open-label phase IV DEFINE trial.
Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.
Patients with unstimulated thyroglobulin (Tg) ≤1 ng/mL or stimulated Tg ≤10 ng/mL who receive radioactive iodine therapy (RAIT) may benefit from a lower recurrence risk of intermediate-risk papillary thyroid cancer (PTC), reveals a study.
Women who use oral contraceptives do not have an excess risk of cardiovascular disease (CVD) events and all-cause death, with the contraceptives potentially conferring benefits to those who have used them for longer, according to a study.
Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.
The use of proton pump inhibitors (PPIs) appears to pose heightened risks of serious infections in young children, according to a study.
The use of relugolix 40 mg in combination with oestradiol 1 mg and norethisterone acetate 0.5 mg (relugolix combination therapy [relugolix-CT]) significantly reduced dysmenorrhea and nonmenstrual pelvic pain (NMPP) in premenopausal women with endometriosis who received prior hormonal treatment, according to a post hoc analysis of two phase III trials presented at ESHRE 2023.
Mortality increases threefold when using colistin to treat infections in liver transplant recipients and by 5 percentage points in renal transplant recipients, a study has shown.
A peer-led demedicalized delivery of same-day HIV pre-exposure prophylaxis (PrEP) in various community centres is feasible, suggests a Philippines study presented at the recent IAS 2023.
